MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.08M
Enterprise Value 335.1M
Trailing P/E 8.16
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1-0.04
Price/Sales (ttm)0.08
Price/Book (mrq)N/A
Enterprise Value/Revenue 30.32
Enterprise Value/EBITDA 6-5.61

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 0.94%
Operating Margin (ttm)-7.29%
Management Effectiveness
Return on Assets (ttm)-12.35%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)108.92M
Revenue Per Share (ttm)8.12
Quarterly Revenue Growth (yoy)-20.30%
Gross Profit (ttm)44.47M
EBITDA -6.25M
Net Income Avi to Common (ttm)1.03M
Diluted EPS (ttm)0.08
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)3.55M
Total Cash Per Share (mrq)0.25
Total Debt (mrq)20.26M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.68
Book Value Per Share (mrq)-0.69
Cash Flow Statement
Operating Cash Flow (ttm)-16.2M
Levered Free Cash Flow (ttm)-28.6M

Trading Information

Stock Price History
Beta 2.79
52-Week Change 3-78.00%
S&P500 52-Week Change 318.22%
52 Week High 32.40
52 Week Low 30.37
50-Day Moving Average 31.05
200-Day Moving Average 31.66
Share Statistics
Avg Vol (3 month) 316.84k
Avg Vol (10 day) 353.89k
Shares Outstanding 514.65M
Float 7.97M
% Held by Insiders 141.00%
% Held by Institutions 111.33%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/850
Last Split Date 3Nov 26, 2012